The change in low-density lipoprotein cholesterol concentration is positively related to plasma docosahexaenoic acid but not eicosapentaenoic acid.
暂无分享,去创建一个
Y. Matsuzawa | K. Shimada | M. Matsuzaki | T. Kita | J. Sasaki | A. Kitabatake | K. Shirato | T. Sakata | S. Oikawa | Yasushi Saito | N. Nakaya | H. Itakura | H. Origasa | M. Yokoyama | H. Hishida | Y. Ishikawa | Y. Saito
[1] A. Minihane,et al. Eicosapentaenoic acid and docosahexaenoic acid from fish oils: differential associations with lipid responses. , 2002, The British journal of nutrition.
[2] S. Egert,et al. Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans. , 2009, The Journal of nutrition.
[3] D. Mozaffarian,et al. Omega-6 Fatty Acids and Risk for Cardiovascular Disease: A Science Advisory From the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention , 2009, Circulation.
[4] Y. Matsuzawa,et al. Effects of purified eicosapentaenoic acid ethyl ester on plasma lipoproteins in primary hypercholesterolemia. , 1992, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.
[5] H. Origasa,et al. Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS). , 2003, American heart journal.
[6] Y. Matsuzawa,et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis , 2007, The Lancet.
[7] G. Franceschini,et al. Omacor in familial combined hyperlipidemia: effects on lipids and low density lipoprotein subclasses. , 2000, Atherosclerosis.
[8] C. Ballantyne,et al. Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins. , 1999, Atherosclerosis.
[9] H. Nihei,et al. Eicosapentanoic acid reduces plasma levels of remnant lipoproteins and prevents in vivo peroxidation of LDL in dialysis patients. , 1999, Journal of the American Society of Nephrology : JASN.
[10] T. A. Jacobson,et al. Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease. , 2008, The American journal of clinical nutrition.
[11] T. A. Jacobson,et al. Erratum: Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: A systematic review and meta-analysis (Current Atherosclerosis Reports (2011) 13 (474-483) DOI:10.1007/s11883-011-0210-3) , 2012 .
[12] J. Luten,et al. The effect of various intakes of omega 3 fatty acids on the blood lipid composition in healthy human subjects. , 1981, The American journal of clinical nutrition.
[13] J. Dyerberg,et al. Fatty acid composition of the plasma lipids in Greenland Eskimos. , 1975, The American journal of clinical nutrition.
[14] T. Hamamoto,et al. Eicosapolyenoic acids of serum lipids of Japanese islanders with low incidence of cardiovascular diseases. , 1982, Journal of nutritional science and vitaminology.
[15] Y. Matsuzawa,et al. Relationships between plasma fatty acid composition and coronary artery disease. , 2011, Journal of atherosclerosis and thrombosis.
[16] A. Zampelas. Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advanced atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. , 2010, Atherosclerosis.
[17] J. Dyerberg,et al. Plasma Lipid and Lipoprotein Pattern in Greenlandic West-Coast Eskimos , 2009 .
[18] H. Ginsberg,et al. Safety and Efficacy of Omacor in Severe Hypertriglyceridemia , 1997, Journal of cardiovascular risk.
[19] W. Harris,et al. The comparative reductions of the plasma lipids and lipoproteins by dietary polyunsaturated fats: salmon oil versus vegetable oils. , 1983, Metabolism: clinical and experimental.
[20] P. Durrington,et al. An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia , 2001, Heart.
[21] N Kromann,et al. Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974. , 2009, Acta medica Scandinavica.
[22] T. A. Jacobson,et al. Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis , 2011, Current atherosclerosis reports.
[23] E. Schaefer,et al. Effects of docosahexaenoic acid on serum lipoproteins in patients with combined hyperlipidemia: a randomized, double-blind, placebo-controlled trial. , 1997, Journal of the American College of Nutrition.